Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapyCristina Puig-Saus, Alena Gros, Barbara Sennino et al.|Nature|2023Cited by 206
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseVeronika Bachanová, Daniel J. Weisdorf, M-J Zhang et al.|Leukemia|2013Cited by 136
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018Steven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 79
A High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Is Obesity a Risk Factor for APL? Implication of Targeted Therapy to Control Obesity and APL Prevention.Julianne Qualtieri, Nishitha Reddy, Jason Tedesco et al.|Blood|2009Cited by 0